|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021641,
umls-concept:C0027121,
umls-concept:C0242692,
umls-concept:C0277785,
umls-concept:C0332307,
umls-concept:C0442027,
umls-concept:C0596620,
umls-concept:C0681850,
umls-concept:C0935929,
umls-concept:C1280500,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1801960,
umls-concept:C2349001,
umls-concept:C2697811
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-5-6
|
|
pubmed:abstractText |
To test potential differences between the actions of anti-diabetic medications, we examined the effects of oral hypoglycaemic agents versus glargine-apidra insulin therapy in T2DM.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Inflammation Mediators,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin, Long-Acting,
http://linkedlifedata.com/resource/pubmed/chemical/Metformin,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonylurea Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/glargine,
http://linkedlifedata.com/resource/pubmed/chemical/hemoglobin A1c protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/insulin glulisine,
http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1520-7560
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
373-82
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21309063-Adult,
pubmed-meshheading:21309063-Body Mass Index,
pubmed-meshheading:21309063-Carotid Arteries,
pubmed-meshheading:21309063-Carotid Artery Diseases,
pubmed-meshheading:21309063-Diabetes Mellitus, Type 2,
pubmed-meshheading:21309063-Diabetic Angiopathies,
pubmed-meshheading:21309063-Drug Combinations,
pubmed-meshheading:21309063-Female,
pubmed-meshheading:21309063-Hemoglobin A, Glycosylated,
pubmed-meshheading:21309063-Humans,
pubmed-meshheading:21309063-Hypoglycemic Agents,
pubmed-meshheading:21309063-Inflammation Mediators,
pubmed-meshheading:21309063-Insulin,
pubmed-meshheading:21309063-Insulin, Long-Acting,
pubmed-meshheading:21309063-Insulin Resistance,
pubmed-meshheading:21309063-Male,
pubmed-meshheading:21309063-Metformin,
pubmed-meshheading:21309063-Mexican Americans,
pubmed-meshheading:21309063-Middle Aged,
pubmed-meshheading:21309063-Muscle, Skeletal,
pubmed-meshheading:21309063-Myositis,
pubmed-meshheading:21309063-Sulfonylurea Compounds,
pubmed-meshheading:21309063-Thiazolidinediones,
pubmed-meshheading:21309063-Tunica Intima
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.
|
|
pubmed:affiliation |
Diabetes Division, Texas Diabetes Institute, University of Texas Health Science Center, San Antonio, TX, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
